Qlucore software used in new project to prevent cardiovascular diseases. Receives SEK 1.5 million to provide patients with better treatment, will play an important role as one of five key partners in the OmegaPerMed project. The project aims to optimize treatment with omega-3 to prevent cardiovascular diseases (CVD).

Cardiovascular diseases, such as heart attack, stroke and angina, are the most common causes of death in populations, and therefore prevention is vital. In clinical trials, the project will try to detect interactions between genes, exposure to polyunsaturated fatty acid (PUFA), CVD risk and lipidomic markers against beneficial CVD effects of omega-3 PUFA. I This means that if successful, patients can be divided into subgroups in order to receive a more individualized treatment.